Elevance Health Inc. ($ELV) Stock Forecast: Down 5.1% Today

What is Elevance Health Inc.?

ELV is the stock symbol for Elevance Health, Inc., a company reaffirming its financial guidance for full year 2026 amidst a bearish market movement today.

Why is Elevance Health Inc. going down?

ELV stock is down 5.1% on Jun 10, 2026 18:56

• The bearish movement in ELV stock could be attributed to the company's reaffirmation of its financial guidance for 2026, which included net unfavorable items affecting earnings per share.
• The announcement of a new contract for Illinois' HealthChoice Medicaid managed care program by a healthcare company might have shifted investor focus towards competitors, impacting ELV's stock negatively.
• The appointment of a new leader to head a Specialty Pharmacy Services unit, emphasizing growth in the specialty pharmacy sector, might have diverted investor attention away from Elevance Health, contributing to the bearish trend.
• A recent study revealing that many Americans delay medical care due to cost implications could have raised concerns about the healthcare industry's overall financial stability, affecting investor sentiment towards healthcare stocks like ELV.

ELV Price Chart

ELV Technical Analysis

ELV News

[8-K] Elevance Health, Inc. Reports Material Event

Elevance Health, Inc. (ELV) filed an 8-K report reaffirming its financial guidance for full year 2026. The company expects at least $19.85 per diluted share in earnings, including approximately $6.90 per diluted share of net unfavorable items, and adjusted shareholders' earnings of at least $26.75 per diluted share. Additionally, the full year 2026 benefit expense ratio guidance remains 90.2% plus or minus 50 basis points.

https://www.stocktitan.net/sec-filings/ELV/8-k-elevance-health-inc-reports-material-event-9d36f1505611.html

Humana Illinois Medicaid Win Adds New Layer To Growth And Valuation

Humana (NYSE:HUM) has secured a new contract for Illinois' HealthChoice Medicaid managed care program, expanding its business beyond its traditional Medicare Advantage focus. This development diversifies Humana's revenue streams, following recent attention on its Orlando pharmacy expansion. Investors will be observing how this new state program integrates with existing operations and impacts the company's growth and profitability, especially given current profit margins of 0.8%.

https://simplywall.st/stocks/us/healthcare/nyse-hum/humana/news/humana-illinois-medicaid-win-adds-new-layer-to-growth-and-va

Omnicell Names Dan Mandoli to Lead Specialty Pharmacy Services Business

Omnicell has appointed Dan Mandoli as senior vice president and general manager of Specialty Pharmacy Services, leveraging his 30 years of experience to expand the company's specialty pharmacy and 340B services. This strategic hire aims to enhance Omnicell's offerings for health systems navigating complex medication management and reimbursement, reinforcing the company's focus on specialty pharmacy as a key growth driver. Mandoli's background includes leadership roles at Altruix, Elevance Health, McKinsey & Company, and Express Scripts, where he focused on scaling specialty pharmacy businesses and optimizing operations.

https://www.citybiz.co/article/856903/omnicell-names-dan-mandoli-to-lead-specialty-pharmacy-services-business/

Omnicell appoints Dan Mandoli to lead specialty pharmacy unit

Omnicell, Inc. has appointed Dan Mandoli as Senior Vice President and General Manager of Specialty Pharmacy Services, leveraging his 30 years of experience in pharmacy operations. This strategic hire is expected to drive growth in Omnicell's Specialty Pharmacy and 340B businesses, which are considered key for delivering value to health systems. The company recently reported strong Q1 2026 results and has a perfect Piotroski Score, indicating strong financial health.

https://www.investing.com/news/company-news/omnicell-appoints-dan-mandoli-to-lead-specialty-pharmacy-unit-93CH-4730702

One in Three Americans Delay Medical Care Due to Cost, HealthEquity Research Finds

A new study by HealthEquity reveals that over one-third of Americans delay or avoid medical care due to cost, leading to significant workplace productivity losses. The research highlights that despite some improvements in benefits understanding, financial preparedness for healthcare expenses has decreased. However, Health Savings Account (HSA) holders show markedly stronger financial readiness and control over healthcare costs, suggesting HSAs are crucial for improving financial resilience.

https://www.globenewswire.com/news-release/2026/06/08/3308312/0/en/one-in-three-americans-delay-medical-care-due-to-cost-healthequity-research-finds.html

Trending Today

Innovative Industrial Properties Inc ($IIPR) Stock Forecast: Up 5.4% Today

Mosaic Company (The) ($MOS) Stock Forecast: Up 5.0% Today

CarMax Inc ($KMX) Stock Forecast: Up 5.2% Today

Ferrari N.V. ($RACE) Stock Forecast: Up 5.2% Today

Capri Holdings Limited ($CPRI) Stock Forecast: Up 5.3% Today

Packaging Corporation of America ($PKG) Stock Forecast: Up 5.2% Today

Circle Internet Group ($CRCL) Stock Forecast: Up 5.0% Today

Jetblue Airways Corporation ($JBLU) Stock Forecast: Up 6.2% Today

Lucid Motors Inc. ($LCID) Stock Forecast: Up 6.3% Today

BlackBerry Limited ($BB) Stock Forecast: Up 5.1% Today

Elevance Health Inc. Price History

10.02.2026 - ELV Stock was up 5.1%

• ELV stock experienced a strong bullish movement today.
• Pinkerton Wealth LLC significantly increased its stake in Elevance Health, indicating confidence in the company's market position and growth potential, which likely contributed to the positive market sentiment.
• The reaffirmation of financial guidance by Centene Corp, a company specializing in health insurance programs, could have also positively influenced ELV's stock as it reflects stability and growth in the healthcare sector.
• The reduction in stake by the Swiss National Bank might have initially raised concerns, but the overall market sentiment seems to have been buoyed by the increased confidence shown by Pinkerton Wealth LLC and the positive industry outlook.

04.05.2026 - ELV Stock was up 5.0%

• The surge in ELV stock can be attributed to the increased 12-month price target, indicating a growing confidence in the company's performance.
• The positive momentum in ELV mirrors the broader trend of healthcare sector rally, with other companies like UnitedHealth and Humana also witnessing substantial gains.
• Analysts endorsing a "Buy" recommendation for ELV, coupled with the positive sector-wide sentiment, signal a shift in investor perception towards healthcare stocks, fueling ELV's bullish market movement.

24.01.2026 - ELV Stock was down 5.2%

• The bearish movement in ELV stock could be attributed to profit-taking by investors after a recent bullish run or concerns about the company's growth prospects.
• The commitment of Elevance Health Foundation to funding food as medicine programs may have diverted investor attention away from ELV, impacting its stock performance negatively.
• Investors may be cautious about ELV's position in the market following news of competitors like Alignment Healthcare reporting membership gains and positive earnings growth.
• The broader market sentiment influenced by news of Humana's weaker earnings outlook and regulatory risks may have also contributed to the bearish trend in ELV stock.

03.02.2026 - ELV Stock was down 6.9%

• Today's downward trend in Elevance Health's stock (ELV) can be attributed to various factors:
• Uncertainty arising among investors due to the recent leadership changes and business consolidation.
• Investors viewing the increased regulatory focus on Elevance Health's Medicare Advantage plans as a potential risk factor.
• The positive news of the company raising its quarterly dividend and having a consensus price target above the current trading price may be overshadowed by ongoing regulatory actions and operational adjustments, contributing to the bearish market movement.

03.02.2026 - ELV Stock was down 6.4%

• The bearish movement in Elevance Health's stock today can be attributed to the threat of Medicare Advantage sanctions by CMS due to noncompliance with data submission requirements, which poses financial and reputational risks for the company.
• The positive news of increased investments by Harvest Portfolios Group Inc. and the South Dakota Investment Council may not have been enough to offset the concerns raised by the CMS sanctions, leading to a decline in investor confidence.
• The launch of a national pilot program to provide free diapers by Elevance Health's subsidiary, Elevance Health, could be seen as a positive social initiative but might not have directly impacted the stock movement significantly.
• Overall, the market sentiment towards Elevance Health seems to be influenced more by regulatory challenges and compliance issues rather than positive investment signals, leading to the bearish movement in the stock today.

28.00.2026 - ELV Stock was up 5.4%

• Elevance Health (ELV) saw a strong bullish movement following a positive reaction to surpassing profit expectations for Q4 2025.
• Despite a mix of results with profits exceeding expectations but revenues falling short investor confidence surged as the company focuses on affordability and platform enhancements.
• Analysts and investors found reassurance in the company's ability to outperform profit expectations and maintain a positive earnings per share outlook for 2026 amidst revenue growth challenges and margin pressures.
• The market shift may have been influenced by general sentiment towards the healthcare and insurance sectors, weighing concerns about margin risks and membership attrition against the company's profit beat and earnings forecast.

23.03.2026 - ELV Stock was up 5.2%

• Adjustments in price targets were made by Barclays and Deutsche Bank, with Barclays raising it to $408 and Deutsche Bank to $363.
• The positive sentiment from analysts following these adjustments likely contributed to the bullish movement.
• CMS issued a threat to block enrollment in Medicare drug plans for Elevance Health, leading to a temporary drop in the stock price.
• Earnings for Q1 2026 surpassed expectations, with an EPS of $12.58 and revenue of $49.49 billion, potentially further fueling the bullish movement.
• Market sentiment may have been influenced by the upcoming Q1 earnings announcement from HCA Healthcare, with analysts monitoring for potential impacts on the healthcare sector.

27.01.2026 - ELV Stock was down 5.5%

• Speculations arose relating to investor concerns prompted by Close Asset Management Ltd's substantial reduction in ELV shares, potentially influencing the bearish market trend.
• The stock's reaffirmed 2026 earnings outlook might not have resonated positively with investors, resulting in a lack of favorable sentiment towards the company.
• Despite Elevance Health's emphasis on responsible AI integration and financial openness, negative market response to the management reshuffle announcements may indicate investor hesitancy.
• The focus on an educational seminar collaboration between Amlan International and Elanco could have diverted attention from Elevance Health, negatively affecting its stock performance as investors turned towards other industry players.

02.02.2026 - ELV Stock was down 4.9%

• The bearish movement in Elevance Health's stock today is linked to CMS imposing sanctions on the company, suspending Medicare enrollment for alleged noncompliance with risk adjustment data submission requirements.
• Despite surpassing quarterly EPS estimates and increasing its dividend, the adverse impact of CMS sanctions appears to overshadow the positive financial performance.
• The contrasting actions of institutional investors, with one increasing its stake significantly while another reducing its holdings, may have contributed to the uncertainty surrounding the stock.
• Elevance Health's efforts to collaborate with CMS and address compliance issues are acknowledged, but market sentiment seems cautious due to impending sanctions impacting the company's Medicare Advantage plans.

12.01.2026 - ELV Stock was up 4.2%

• ELV stock showed a significant bullish movement recently, potentially influenced by various factors:
• Wealthfront Advisers LLC notably increased its stake in ELV, suggesting optimism regarding the company's future prospects and financial performance.
• Although Zacks Research lowered its EPS forecast, ELV surpassed earnings expectations in the last quarter, raised its dividend, likely boosting investor confidence.
• Analysts' "Moderate Buy" rating and an average price target of $390.55 indicate a positive sentiment towards ELV, potentially contributing to the recent stock movement.
• The company's ability to maintain robust performance despite challenges from a shrinking customer base demonstrates resilience and growth potential, appealing to investors seeking opportunities in a competitive market.

12.04.2026 - ELV Stock was up 3.5%

• ELV stock experienced a strong bullish movement.
• The positive earnings report and raised guidance by Elevance Health (ELV) likely contributed to the bullish trend.
• Investors were attracted by the company's performance in commercial and Medicare segments, as well as its capital return plans, making ELV a favorable option in the managed care sector.
• The overall optimism surrounding ELV's financial health and growth prospects propelled the stock higher, showcasing investor confidence in the company's future trajectory.

10.05.2026 - ELV Stock was down 5.1%

• The bearish movement in ELV stock could be attributed to the company's reaffirmation of its financial guidance for 2026, which included net unfavorable items affecting earnings per share.
• The announcement of a new contract for Illinois' HealthChoice Medicaid managed care program by a healthcare company might have shifted investor focus towards competitors, impacting ELV's stock negatively.
• The appointment of a new leader to head a Specialty Pharmacy Services unit, emphasizing growth in the specialty pharmacy sector, might have diverted investor attention away from Elevance Health, contributing to the bearish trend.
• A recent study revealing that many Americans delay medical care due to cost implications could have raised concerns about the healthcare industry's overall financial stability, affecting investor sentiment towards healthcare stocks like ELV.